MENLO PARK, Calif.--(BUSINESS WIRE)--Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the ...
A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...